Early recognition of postoperative hematoma formation

1988 ◽  
Vol 107 (4) ◽  
pp. 253-255 ◽  
Author(s):  
F. Glaser ◽  
W. Knopp ◽  
G. Muhr
1978 ◽  
Vol 86 (2) ◽  
pp. ORL-171-ORL-175 ◽  
Author(s):  
Jonas T. Johnson ◽  
Charles W. Cummings

The role of hematoma formation in the development of complications after major head and neck surgery is surveyed retrospectively. An incidence of 4.2% was encountered. In all cases, the hematoma was identified within 12 hours postoperatively. Prompt surgical clot evacuation and reinstitution of drainage did not adversely affect the patient's subsequent course. Failure to adequately drain the hematoma resulted in increased wound dehiscence, major infection, and fistula. When properly treated, postoperative hematoma formation offers only the risks attendant with a second anesthesia; no subsequent related morbidity need be anticipated.


1989 ◽  
Vol 71 (1) ◽  
pp. 38-41 ◽  
Author(s):  
Kwan-Hon Chan ◽  
Kirpal S. Mann ◽  
T. K. Chan

✓ A group of 35 patients undergoing intracranial surgery who exhibited perioperative thrombocytopenia (platelet count < 150,000/µl) was studied retrospectively. Of the 35 patients, 14 (40%) developed postoperative intracranial hematomas requiring reoperation and seven (20%) died within 2 weeks after the operation. Analysis revealed that a perioperative platelet count below 100,000/µl in a patient who failed to respond to platelet transfusions was associated with a higher risk of postoperative hematoma formation. All six patients with this profile developed postoperative hematomas. If the platelet count rose promptly from below 100,000/µl to a normal level after platelet transfusions, the incidence of hematoma formation decreased dramatically. None of the three patients with this response developed postoperative hematoma. In patients in whom an acute drop in platelet count from the normal range to between 100,000 and 124,000/µl occurred in the immediate perioperative period, there was a significantly higher chance of hematoma formation; this finding has not hitherto been described. Of the 14 patients with this clinical course, eight developed postoperative hematoma after craniotomy for tumors and vascular lesions. This latter observation was substantiated by the fact that thrombocytopenic patients with postoperative hematomas had a greater reduction in platelet count than thrombocytopenic patients with no postoperative hematomas (p = 0.0004).


2018 ◽  
Vol 142 (5) ◽  
pp. 632e-638e ◽  
Author(s):  
Joseph M. Firriolo ◽  
Laura C. Nuzzi ◽  
Lauren C. Schmidtberg ◽  
Brian I. Labow

1989 ◽  
Vol 83 (4) ◽  
pp. 692-698 ◽  
Author(s):  
Harvey N. Himel ◽  
Marsood Ahmad ◽  
Steven R. Parmett ◽  
H. William Strauss ◽  
James W. May

2012 ◽  
Vol 97 (2) ◽  
pp. 150-154 ◽  
Author(s):  
Thair M. Al-Dujaili ◽  
Catalin N. Majer ◽  
Tarek E. Madhoun ◽  
Sebouh Z. Kassis ◽  
Alaa A. Saleh

Abstract Deep venous thrombosis (DVT) is a significant health care problem; a variety of factors place spinal surgery patients at high risk for DVT. Our aim is to define the incidence of DVT occurrence in spite of prophylactic measures (mechanical and chemoprophylaxis), and the development of spinal epidural hematoma as a complication of chemoprophylaxis. In a single-center prospective study, 158 patients who underwent spinal surgical procedures were evaluated by clinical evaluation and lower limb Doppler ultrasonography imaging. Only one patient (0.6%) developed DVT; this patient was treated successfully without thrombus progression, with full recanalization. Three patients (1.8%) developed spinal epidural hematoma, but only one required surgical evacuation, and none sustained neurologic deficit. Careful evaluation for DVT risk on an individual basis and good prophylaxis helps to minimize the risk of DVT. The neurosurgeon is thus left to weigh the risks of postoperative hematoma formation against the benefits of protecting against DVT.


1989 ◽  
Vol 83 (4) ◽  
pp. 699-700
Author(s):  
Harvey N. Himel ◽  
Marsood Ahmad ◽  
Steven R. Parmett ◽  
H. William Strauss ◽  
James W. May ◽  
...  

Author(s):  
Elizabeth Laikhter ◽  
Carly D Comer ◽  
Eric Shiah ◽  
Samuel M Manstein ◽  
Paul A Bain ◽  
...  

Abstract Background Recent evidence suggests tranexamic acid (TXA) may improve outcomes in aesthetic surgery patients. Objectives This systematic review aimed to investigate the impact of TXA use in aesthetic plastic surgery on bleeding and aesthetic outcomes. Methods A systematic literature search was conducted to identify studies evaluating TXA use in aesthetic plastic surgery. The primary outcome of interest was perioperative bleeding, reported as total blood loss (TBL), ecchymosis, and hematoma formation. Meta-analyses analyzing TBL, and postoperative hematoma were performed. Results Of 287 identified articles, 14 studies evaluating TXA use in rhinoplasty (6), rhytidectomy (3), liposuction (3), reduction mammaplasty (1), and blepharoplasty (1) were included for analysis. Of 820 total patients, 446 (54.4%) received TXA. Meta-analysis demonstrated TXA is associated with 26.3mL average blood loss reduction (95% CI: -40.0mL to -12.7mL, p &lt; 0.001) and suggested a trend toward decreased odds of postoperative hematoma with TXA use (OR: 0.280, 95% CI: 0.076 - 1.029, p = 0.055). Heterogeneity among reporting of other outcomes precluded meta-analysis; however, 5 of 7 studies found significantly decreased postoperative ecchymosis levels within 7 days of surgery, three studies found statistically significant reductions in postoperative drain output, and one study reported significantly improved surgical site quality for patients who received TXA (p = 0.001). Conclusions TXA is associated with decreased blood loss and a trend toward decreased hematoma formation in aesthetic plastic surgery. Its use has the potential to increase patient satisfaction with postoperative recovery and decrease costs associated with complications, including hematoma evacuation.


Sign in / Sign up

Export Citation Format

Share Document